Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 5
1988 13
1989 3
1990 3
1991 8
1992 3
1994 4
1995 9
1996 2
1997 4
1998 1
2002 3
2003 4
2005 1
2006 3
2007 1
2008 2
2009 5
2010 1
2012 4
2013 3
2014 4
2015 6
2016 5
2017 2
2018 1
2019 3
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32561613

102 results
Results by year
Filters applied: . Clear all
Page 1
Flecainide toxicity in a neonate with supraventricular tachycardia.
Zeigler VL, Peterson J. Zeigler VL, et al. Heart Lung. 1991 Nov;20(6):689-91. Heart Lung. 1991. PMID: 1960074
Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia.
Doki K, Homma M, Kuga K, Kusano K, Watanabe S, Yamaguchi I, Kohda Y. Doki K, et al. Eur J Clin Pharmacol. 2006 Nov;62(11):919-26. doi: 10.1007/s00228-006-0188-x. Epub 2006 Aug 30. Eur J Clin Pharmacol. 2006. PMID: 16944116
Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia.
Doki K, Homma M, Kuga K, Aonuma K, Sakai S, Yamaguchi I, Kohda Y. Doki K, et al. Eur J Clin Pharmacol. 2007 Oct;63(10):951-7. doi: 10.1007/s00228-007-0348-7. Epub 2007 Jul 31. Eur J Clin Pharmacol. 2007. PMID: 17665182 Clinical Trial.
Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects.
Lim KS, Jang IJ, Kim BH, Kim J, Jeon JY, Tae YM, Yi S, Eum S, Cho JY, Shin SG, Yu KS. Lim KS, et al. Clin Ther. 2010 Apr;32(4):659-66. doi: 10.1016/j.clinthera.2010.04.002. Clin Ther. 2010. PMID: 20435235
Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity.
Doki K, Sekiguchi Y, Kuga K, Aonuma K, Homma M. Doki K, et al. Drug Metab Pharmacokinet. 2015 Aug;30(4):257-62. doi: 10.1016/j.dmpk.2015.04.001. Epub 2015 Apr 11. Drug Metab Pharmacokinet. 2015. PMID: 26195225
Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG. Hopson JR, et al. Am J Cardiol. 1996 Jan 25;77(3):72A-82A. doi: 10.1016/s0002-9149(97)89121-7. Am J Cardiol. 1996. PMID: 8607395 Clinical Trial.
102 results
Jump to page
Feedback